The majority of Americans living with asthma sit firmly in the poverty range, making it difficult or impossible to get lifesaving care. Fortunately, nonprofit patient assistance programs (PAP) are stepping up, connecting uninsured or underinsured low-income patients access asthma care. However, the programs don’t just offer care, according to Accessia Health CEO Gwen Cooper.
The UK’s National Institute for Health and Care Excellence (NICE) released a final draft guidance recommending the use of Amgen and Astrazeneca’s Tezspire in maintenance treatment for some patients with severe asthma. The biologic is the only one of its kind, targeting an important asthma-related inflammatory protein.
Health disparities in asthma and eczema have been observed in Black children, but little research has explored the combination of the two. In research presented at this year’s American Academy of Allergy, Asthma, and Immunology (AAAAI) meeting, researchers explored the social determinants of health (SDoH) underlying this heath disparity. In addition, another abstract investigated the increased rate of childhood asthma-related respiratory infections in Black and Mexican-American patients.
A set of studies published in the Archives of Disease in Childhood and the Journal of Asthma found that patients with childhood asthma benefit from regular general practitioner (GP) visits but unfortunately do not get enough of them. Only 20% saw their GP for a majority of their visits, with less than 40% seeing their GP in the week following a hospital discharge for asthma-related reasons.